The indirect cost of Chronic Fatigue Syndrome is staggering, up to 836 000 and 2.5 million individuals are affected in the United States alone before COVID-19 struck [5]
Analysis: The peptide problem: Hype is outrunning the evidence With flimsy or no evidence that using unauthorized peptide drugs is effective in humans, buying the online and self-injecting is high-risk, uncontrolled human self-experimentation, writes Stuart Phillips
When GHK-Cu is combined with BPC-157 and TB-500, all three peptides are typically dosed on their individual schedules and may be administered in the same subcutaneous session or separately based on physician preference
Claims about longevity are not established by gold-standard human trials
Further studies are needed to determine the most ideal dosage and administration route for a greater bioavailability of NAC
Teskey G, Abrahem R, Cao R, Gyurjian K, Islamoglu H, Lucero M, et al